89 Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study.

Autor: Linders, D. G. J.1 (AUTHOR) d.e.hilling@lumc.nl, Deken, M. M.1 (AUTHOR), van Dam, M. A.1 (AUTHOR), Wasser, M. N. J. M.2 (AUTHOR), Voormolen, E. M. C.2 (AUTHOR), Kroep, J. R.3 (AUTHOR), van Dongen, G. A. M. S.4 (AUTHOR), Vugts, D.4 (AUTHOR), Oosterkamp, H. M.5 (AUTHOR), Straver, M. E.6 (AUTHOR), van de Velde, C. J. H.1 (AUTHOR), Cohen, D.7 (AUTHOR), Dibbets-Schneider, P.8 (AUTHOR), van Velden, F. H. P.8 (AUTHOR), Pereira Arias-Bouda, L. M.8,9 (AUTHOR), Vahrmeijer, A. L.1 (AUTHOR), Liefers, G. J.1 (AUTHOR), de Geus-Oei, L. F.8,10,11 (AUTHOR), Hilling, D. E.1,12 (AUTHOR)
Zdroj: Cancers. Oct2023, Vol. 15 Issue 20, p4980. 16p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje